PMID- 20308932 OWN - NLM STAT- MEDLINE DCOM- 20110110 LR - 20220331 IS - 1529-7535 (Print) IS - 1529-7535 (Linking) VI - 11 IP - 5 DP - 2010 Sep TI - Prevalence of adverse events in pediatric intensive care units in the United States. PG - 568-78 LID - 10.1097/PCC.0b013e3181d8e405 [doi] AB - OBJECTIVES: Selection of relevant patient safety interventions for the pediatric intensive care (PICU) requires identification of the types and severity of adverse events (AEs) and adverse drug events (ADEs) that occur in this setting. The study's objectives were to: 1) determine the rates of AEs/ADEs, including types, severity, and preventability, in PICU patients; 2) identify population characteristics associated with increased risk of AEs/ADEs; 3) develop and test a PICU specific trigger tool to facilitate identification of AEs/ADEs. DESIGN, SETTING, PATIENTS: Retrospective, cross-sectional, randomized review of 734 patient records who were discharged from 15 U.S. PICUs between September and December 2005. INTERVENTION: A novel PICU-focused trigger tool for AE/ADE detection. MEASUREMENTS AND RESULTS: Sixty-two percent of PICU patients had at least one AE. A total of 1488 AEs, including 256 ADEs, were identified. This translates to a rate of 28.6 AEs and 4.9 ADEs per 100 patient-days. The most common types of AEs were catheter complications, uncontrolled pain, and endotracheal tube malposition. Ten percent of AEs were classified as life-threatening or permanent; 45% were deemed preventable. Higher adjusted rates of AEs were found in surgical patients (p = .02), patients intubated at some point during their PICU stay (p = .002), and patients who died (p < .001). Surgical patients had higher preventable adjusted AE (p = .01) and ADE rates (p = .02). The adjusted cumulative risk of an AE per PICU day was 5.3% and 1.6% for an ADE alone. There was a 4% increase in adjusted ADEs rates for every year increase in age. CONCLUSIONS: AEs and ADEs occur frequently in the PICU setting. These data provide areas of focus for evidence-based prevention strategies to decrease the substantial risk to this vulnerable pediatric population. FAU - Agarwal, Swati AU - Agarwal S AD - Virginia Commonwealth University School of Medicine, Inova Campus, Pediatric Critical Care, Inova Fairfax Hospital for Children, Falls Church, VA, USA. swati.agarwal@inova.org FAU - Classen, David AU - Classen D FAU - Larsen, Gitte AU - Larsen G FAU - Tofil, Nancy M AU - Tofil NM FAU - Hayes, Leslie W AU - Hayes LW FAU - Sullivan, Janice E AU - Sullivan JE FAU - Storgion, Stephanie A AU - Storgion SA FAU - Coopes, Barbara J AU - Coopes BJ FAU - Craig, Vicki AU - Craig V FAU - Jaderlund, Christine AU - Jaderlund C FAU - Bisarya, Hema AU - Bisarya H FAU - Parast, Layla AU - Parast L FAU - Sharek, Paul AU - Sharek P LA - eng PT - Journal Article PT - Multicenter Study PL - United States TA - Pediatr Crit Care Med JT - Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies JID - 100954653 SB - IM CIN - Pediatr Crit Care Med. 2010 Sep;11(5):632-3. PMID: 20823738 MH - Adolescent MH - Adult MH - Age Distribution MH - Child MH - Child, Preschool MH - Cross-Sectional Studies MH - Drug-Related Side Effects and Adverse Reactions/classification/epidemiology MH - Female MH - Hospital Mortality MH - Humans MH - Infant MH - Intensive Care Units, Pediatric/*statistics & numerical data MH - Length of Stay/statistics & numerical data MH - Male MH - Medical Errors/classification/prevention & control/*statistics & numerical data MH - Medication Errors/statistics & numerical data MH - Prevalence MH - Retrospective Studies MH - Risk Factors MH - Sex Distribution MH - United States/epidemiology EDAT- 2010/03/24 06:00 MHDA- 2011/01/11 06:00 CRDT- 2010/03/24 06:00 PHST- 2010/03/24 06:00 [entrez] PHST- 2010/03/24 06:00 [pubmed] PHST- 2011/01/11 06:00 [medline] AID - 10.1097/PCC.0b013e3181d8e405 [doi] PST - ppublish SO - Pediatr Crit Care Med. 2010 Sep;11(5):568-78. doi: 10.1097/PCC.0b013e3181d8e405.